HBK Sorce Advisory LLC Acquires Shares of 1,267 HCA Healthcare, Inc. $HCA

HBK Sorce Advisory LLC bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,267 shares of the company’s stock, valued at approximately $540,000.

Several other institutional investors have also modified their holdings of the stock. Exchange Traded Concepts LLC increased its position in shares of HCA Healthcare by 54.8% during the 3rd quarter. Exchange Traded Concepts LLC now owns 38,266 shares of the company’s stock valued at $16,309,000 after purchasing an additional 13,547 shares during the last quarter. Brighton Jones LLC lifted its holdings in shares of HCA Healthcare by 8.2% in the 3rd quarter. Brighton Jones LLC now owns 3,934 shares of the company’s stock worth $1,677,000 after acquiring an additional 298 shares during the last quarter. Trust Point Inc. bought a new position in HCA Healthcare during the 3rd quarter valued at about $289,000. Abound Wealth Management lifted its stake in HCA Healthcare by 28.0% in the third quarter. Abound Wealth Management now owns 119 shares of the company’s stock worth $51,000 after purchasing an additional 26 shares during the last quarter. Finally, Astoria Portfolio Advisors LLC. purchased a new stake in shares of HCA Healthcare in the third quarter worth approximately $354,000. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Wall Street Zen raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 25th. Truist Financial lifted their price objective on shares of HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a report on Monday, October 27th. TD Cowen upped their target price on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Bank of America boosted their price target on HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a report on Monday, October 27th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and set a $417.00 target price on shares of HCA Healthcare in a research report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $479.00.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $474.06 on Friday. The business has a fifty day moving average price of $474.62 and a 200 day moving average price of $419.32. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The stock has a market capitalization of $108.18 billion, a P/E ratio of 18.32, a price-to-earnings-growth ratio of 1.40 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.